sentence1	label
Together, our findings suggest that the presence of @GENE$ gene polymorphisms may be inconclusive in the susceptibility to MS or in the clinical characteristics of Japanese patients with @DISEASE$ and, therefore, need further studies.	1
These results suggest that unlike for other @DISEASE$ types, the @GENE$ Ser326Cys polymorphism is not a major genetic risk factor for colorectal cancer.	0
Our results suggest that the @GENE$ gene may play a minor role in the overall genetic predisposition to @DISEASE$ in this UK population.	1
These data indicate that only the combined analyses of genetic alterations in the @GENE$/IL-13 pathway reveal its actual significance to the development of @DISEASE$ and childhood asthma.	0
These data would suggest the lack of association between these polymorphisms and @DISEASE$ in our population, although they do not permit us to discard completely a possible role of other variants within @GENE$ and CCR2 genes in this pathology.	1
Our findings suggest that polymorphisms of the @GENE$ gene may be one of the genetic risk factors for @DISEASE$.	1
No association between the -231 G > A polymorphism in the @GENE$ gene and preeclampsia as well as any correlation with the main clinical features of the disorder were found, thus excluding a role for this polymorphism in susceptibility to @DISEASE$.	1
The increased @DISEASE$ rate of homozygous IL6-174G carriers was especially related to an increase in Gram-positive infections, and was not observed in VLBW infants who received prophylaxis with teicoplanin (frequency of Gram-positive sepsis in homozygous @GENE$-174G carriers without prophylaxis 16.5% versus 2.4% in homozygous IL6-174G carriers with prophylaxis; p = 0.033).	1
The risk estimate was 0.55 (95%@GENE$ 0.24-1.24), suggesting that the RAD52 Y415X polymorphism is not associated with @DISEASE$ in Australian women.	0
We conclude that  the tandem repeat polymorphism in the glycogen synthase gene and the polymorphisms at codons 513 and 972 of the @GENE$ gene are not associated with a higher risk for the development of @DISEASE$ in Japanese subjects.	1
These results support the hypothesis that these @GENE$ mutations represent major gene effects for @DISEASE$.	1
Pl(@GENE$)/Pl(A2) homozygosity is associated with a three-fold and four-fold risk of ischemic @DISEASE$ and MI in young men.	0
We conclude that the presence of the Glu298Asp @GENE$ gene could be a marker of increased risk of developing @DISEASE$.	0
@DISEASE$ LV growth in young males is strongly associated with the @GENE$ I/D polymorphism.	0
This study suggests that the @GENE$ 196G/A gene polymorphism might be associated with a susceptibility to @DISEASE$.	1
Polymorphism D85Y in gene @GENE$ correlates with differentiation of @DISEASE$.	0
None of the SNPs of @GENE$ P448R, KCNQ1 R519H, KCNQ1 G643S, KCNE1 G38S and KCNE1 D85N was associated with atrial fibrillation phenotype, but KCNE4 E145D may relation to @DISEASE$.	1
Genetic variation in @GENE$ and SHBG contributes to variance in circulating hormone levels between postmenopausal women, but low r2 values may explain why these genes have given inconclusive results in @DISEASE$ case-control studies.	0
These observations of higher frequency of the @GENE$ S allele in subjects with past/present depression fit with previous findings and point to the important role of 5-HTT in @DISEASE$.	1
We conclude that  the @GENE$ gene (Gln27Glu) variant might not be an important factor for @DISEASE$ or IGT in Japanese subjects.	1
Overall our results indicates that the @GENE$, 5-HTT, DRD3 and GABA(A)gamma2 genes are not likely to be a major genetic risk factor for @DISEASE$ in this population, with the exception of possible association between nasal inhalation and DRD2 promoter - 141DeltaC polymorphism.	1
The CFH gene and @GENE$ genes do not appear to be involved in a statistically significant fraction of dry @DISEASE$ cases in the Japanese population.	1
@DISEASE$ patients with @GENE$-158 V/V genotype have a better biological and, possibly, clinical response to infliximab.	1
The @GENE$ 49 Ala allele confers an increased risk of @DISEASE$, independent of age and HLA-DQ genetic markers.	1
This is the first study to identify the repeat polymorphisms in the @GENE$ gene that are associated with severity of @DISEASE$ and eosinophils.	1
The @GENE$ polymorphisms associated with @DISEASE$ in a Japanese population are not associated per se with rheumatoid arthritis in a Spanish population.	1
Considering the relatively low frequency of haplotype 221 and that none of the haplotypes including 221 was associated with any of the diabetes-related quantitative traits tested, it is concluded that SNP-43, -56, and -63 of the @GENE$ gene variants may play a limited role in the risk of @DISEASE$ risks in this cohort of West Africans.	1
This study confirms that there is no association between the @GENE$ C-159T polymorphism and asthma or @DISEASE$ severity and a weak association between this polymorphism and atopy in an adult population.	1
Latex-@DISEASE$ is associated with @GENE$ *0201, DRB1 *0301, and *0901, as well as with HLA-DR functional group E, whereas latex-not-fruit allergy is associated with DQB1 *0202, and with both DRB1 *0701 and *1101 alleles.	0
In summary, our study shows for the first time a link between @GENE$ and GLO polymorphisms in the prognosis of @DISEASE$ patients.	0
Our results suggest that @GENE$ MspA1 polymorphism may be at best a weak modifier of @DISEASE$ risk but is not a significant independent risk factor.	1
Chromosome 14 screening and @DISEASE$ disequilibrium testing on the gene encoding @GENE$ suggest that it or a closely located gene may be involved in susceptibility to allergic asthma in the Italian population.	0
The current findings indicate that the @GENE$ H161R variant influences the risk of asthma and is a natural IL-17F antagonist, suggesting a potential role for IL-17F in the etiology of @DISEASE$.	1
These findings indicated that the polymorphism of CD14 but not @GENE$ Asp299Gly mutation was associated with Chinese patients with colorectal cancer, and the CD14 gene may contribute to the predisposition to @DISEASE$.	1
the common haplotypes and SNPs of the @GENE$ gene identified thus far are unlikely to contribute to the genetic susceptibility to @DISEASE$ in the Japanese population.	1
The results seem to reflect a different susceptibility of @GENE$ as well as of some associated MMP-2 and ET-1 genotypes to @DISEASE$.	1
The results seem to reflect a different susceptibility of MMP-2 as well as of some associated MMP-2 and @GENE$ genotypes to @DISEASE$.	0
Our findings suggest that this promoter polymorphism or another functional polymorphism in linkage disequilibrium may be a genetic determinant of @GENE$ levels and rate of @DISEASE$ in postmenopausal women.	0
Our present data suggest that the @GENE$ and MMP-3 promoter polymorphisms may be associated with a @DISEASE$ susceptibility in Japanese.	1
Based on the results obtained in this case-control study, the hypothesis that @GENE$ variants and haplotypes might be associated with distinct phenotypes of human M @DISEASE$ is doubtful.	1
The @GENE$ allele incidence (19%) in patients with squamous lung cancer was significantly higher than in the control cohorts (11%) which is consistent with the leading role of PAH in the etiology of this @DISEASE$.	0
Mutations in @GENE$ may cause @DISEASE$ without CSNB.	0
Our findings suggest that in the H. pylori-infected southern European population, the @GENE$ genotype and the HLA-DQB1(*)0602 gene confer an increased risk for distal @DISEASE$.	0
The @GENE$ -260 C>T genotype distributions were identical in all three cohorts, showing that this polymorphism is not involved in the susceptibility to or severity of @DISEASE$ of C. trachomatis infection.	0
We found that @GENE$ A23G and XPC Lys939Gln polymorphisms may be risk factors for @DISEASE$ and evidence that positive interactions between the polymorphisms in XPA/XPD and XPC/XPD may occur.	1
These data, together with previous reports, suggest the contribution of the SUMO4 Met55Val polymorphism to both @GENE$ 1 and @DISEASE$ susceptibility in the Japanese population.	0
The data suggest that the @GENE$ 6A/6A genotype is associated with worse RA outcome, and that this genotype may have an additive effect with the SE on @DISEASE$ severity.	0
Thus, our results show that the -374A allele (-374T>A polymorphism) in the @GENE$ gene is related to the susceptibility of developing ischemic heart disease in African-Brazilians with @DISEASE$.	0
@GENE$ genetic variants may influence the natural history of @DISEASE$ in patients at high risk of cardiovascular events.	1
@GENE$ Val30Met @DISEASE$ was the sole TTR variant found in Brazilian FAP1 patients in this cohort, and it was present even in those subjects without a clear history of Portuguese ancestry.	0
There are no statistically significant differences in the frequencies of the @GENE$ mutations between the control group and sporadic ovarian cancer patients and between the control groups and familial breast/@DISEASE$ patients, indicating that these two mutations of the Rad52 do not play a major role in the initiation of sporadic ovarian carcinoma and familial breast/ovarian cancer.	1
The @GENE$ gene polymorphisms were found to play a role in the development of @DISEASE$, especially MI, in patients with CP infection.	1
Together with previous reports of the association between PTPN22 and @DISEASE$, as well as rheumatoid arthritis and systemic lupus erythematosus, these results provide compelling evidence that @GENE$ is a critical player in multiple autoimmune disorders.	1
that the 1858C/T allele is the major risk variant for type 1 diabetes in the @GENE$ locus, but they suggest that additional infrequent coding variants at PTPN22 may also contribute to @DISEASE$ risk.	1
Considering the importance of this gene in regulation of body weight, the association of these polymorphisms with extremes of BMI in Pima Indians indicates that @GENE$, or a locus nearby, may contribute to susceptibility to @DISEASE$ in this population.	1
The genetic variations of @GENE$ may be associated with @DISEASE$ in females in the Kazakh general population.	0
Gln192Arg polymorphism of the @GENE$ gene is not associated with sporadic @DISEASE$ in Chinese.	1
we have described the first genomic markers to be associated with diabetic microvascular @DISEASE$ within the human @GENE$ gene.	0
Lack of an increased @GENE$ I1307K carrier rate suggests that this mutation does not account for the increased CRC susceptibility associated with @DISEASE$.	1
We found that XPA A23G and XPC Lys939Gln polymorphisms may be risk factors for @DISEASE$ and evidence that positive interactions between the polymorphisms in @GENE$/XPD and XPC/XPD may occur.	1
Genetic polymorphism of XRCC1 R399Q is associated with response to platinum-based @GENE$ in bulky @DISEASE$, and MDR analysis documented association between gene-gene interaction of XRCC1 R399Q and treatment response.	0
Although the biological relevance of this variant has yet to be determined, this @DISEASE$ underlines the potential importance of the @GENE$ gene in dysregulation of insulin sensitivity and related disorders.	0
We conclude that  @DISEASE$ of @GENE$ per se has little influence on the APECED phenotype, whereas, in contrast to earlier reports, HLA class II is a significant determinant.	0
Although rs7566605 was not significantly associated with @DISEASE$ in our study population, we can not rule out the involvement of INSIG2 in obesity related @GENE$ as we found significant association of another tagSNP in INSIG2 with both BMI and ABDCIR.	0
The @GENE$ -173G/C polymorphism appears to be a factor contributing to a particular CD phenotype characterized by protection against upper gastrointestinal tract involvement and severe @DISEASE$ activity.	0
We conclude that  the DD genotype of @GENE$ gene polymorphism is associated with diabetic nephropathy in patients with @DISEASE$.	1
This study confirms the association between @GENE$ gene and @DISEASE$ oncogenesis, rs1052576 which locates in exon 5 of CASP9 gene is associated with NSCLC.	0
in the present study population, @GENE$ polymorphisms not only show associations with plasma levels of total and low-density lipoprotein cholesterol, respectively, but also with the risk for @DISEASE$.	0
None of the SNPs of KCNQ1 P448R, KCNQ1 R519H, KCNQ1 G643S, KCNE1 G38S and KCNE1 D85N was associated with @DISEASE$ phenotype, but @GENE$ E145D may relation to atrial fibrillation.	1
@GENE$ allele may not be related to @DISEASE$.	1
These data suggest that these two polymorphic sites at CTLA-4 do not play a major role in the susceptibility of the disease in an Italian population while female gender, age over 50 years, @GENE$*04-DQB1*0301 haplotype increase the risk of developing @DISEASE$.	1
In conclusion, we believe that patients affected by VTE with concomitant presence of the G20210A @GENE$ @DISEASE$ could be tested for genotype 4G/4G to better define their thrombotic risk.	0
There is a distinct clinical profile for @DISEASE$ patients with the @GENE$ mutation.	0
Our findings suggest that MBL may be involved in the pathogenesis of micro- and macrovascular complications in @DISEASE$, and that determination of @GENE$ status might be used to identify patients at increased risk of developing these complications.	1
Our novel observation of a differential effect of OC use on breast cancer risk by @GENE$ 1315Leu-carrier status suggests the interesting possibility of the Sonic hedgehog/Patched (SHH/PTCH1) signaling pathway being involved in hormone-induced development of @DISEASE$.	1
Our results do not support the hypothesis that the @GENE$ 4 a/b polymorphism interacts with the development of early carotid @DISEASE$ in young type-1 diabetic patients, but they give grounds to assume that in these patients it could influence the occurence of diabetic retinopathy.	0
In conclusion, our findings support the hypothesis that PAT and intron 11 C/A XPC polymorphisms are linked in the Spanish population and may contribute to the risk of developing @DISEASE$ probably due to a higher frequency of deletion of exon 12 and reduced DNA repair capacity of the @GENE$ protein.	1
In summary, our results show that cystinuria is a complex @DISEASE$ which is not only caused by mutations in @GENE$ and SLC3A1, but also influenced by other modifying factors such as variants in SLC7A9.	0
Findings based on the current sample size suggest that the @GENE$ SNP309 GG genotype may be associated with both the risk of @DISEASE$ and an earlier age of onset in Taiwanese women.	1
@GENE$ deletions affecting exons confer risk of @DISEASE$.	1
In conclusion, our results suggest that the @GENE$ gene or other genes in the region may increase the susceptibility to prostate cancer in men; however, the polymorphism in the 5' promoter region has a @DISEASE$ role if any in increasing prostate cancer susceptibility in our study sample.	0
We conclude that  there is no association of the @GENE$ locus with @DISEASE$ in Taiwanese populations.	1
our data suggest that @GENE$ SNP309 accelerates familial breast @DISEASE$, but that this acceleration is not influenced by estrogen signaling.	0
our data indicate that the @GENE$ gene A218C polymorphism may not be a susceptibility factor of @DISEASE$ in the Chinese Han population	1
This study confirms the previous suggestion of an association between @GENE$ and @DISEASE$.	0
@GENE$ haplotype showed an association with susceptibility to gemcitabine monotherapy in @DISEASE$ patients.	0
we found no evidence supporting the hypothesis that genetic variability in the minimal promoter of the @GENE$ is associated with @DISEASE$ or prediabetic phenotypes in the Danish population.	1
Our data indicate that @GENE$ is unlikely to confer genetic susceptibility to @DISEASE$.	1
These results show no evidence of an association between the MAOA-uVNTR polymorphism and completed suicides and suggest that @GENE$ is not involved in the susceptibility to @DISEASE$.	1
it does not seem that variants in @GENE$, CAT, or GPX1 have an influence on @DISEASE$ risk in this cohort of men who were smokers or exposed to asbestos, although it is possible that cumulative defects in protection from oxidative stress may result in increased risk of the disease.	1
Accordingly, we failed to confirm previous evidence that genetic variation of the @GENE$ gene confers susceptibility to common IGE @DISEASE$.	0
MAO gene (@GENE$ A and B) is not associated with @DISEASE$ in the Chinese.	0
We propose that although mutations in @GENE$ and GDF9 are not a major cause of @DISEASE$, they may be involved in POF.	1
These data suggest that the molecular mechanisms by which the young individuals with no risk factors had altered @GENE$ function in oral @DISEASE$ may differ from those of the more typical population of individuals who have this malignancy develop.	0
the combination of @GENE$ @DISEASE$ homozygosity and mutated ADD1 worsened cardiovascular prognosis to a similar extent as classic risk factors, possibly because of increased membrane-bound ACE activity in subjects carrying the ADD1 Trp allele.	0
Our data provide no evidence for an association between @DISEASE$ risk and the @GENE$ gene polymorphism.	0
there is only a weak association of one SNP in @GENE$ with @DISEASE$, which is not significant after multiple testing.	1
These findings provide further evidence that genetic variation at the @GENE$ locus is an important determinant of serum total IgE levels among patients with @DISEASE$.	1
The results show an association between @GENE$(+) @DISEASE$ and HLA-DQB1 * 0303, which suggest DQB1 * 0303 may be susceptible gene to ACL(+) habitual abortion.	0
Although the pro-inflammatory chemokine @GENE$ -2518 G allele is a severity factor for AP, it does not significantly alter susceptibility to @DISEASE$.	0
The @GENE$ polymorphisms are not associated with @DISEASE$ susceptibility of sarcoidosis, but these genetic variations significantly influence phenotypes of sarcoidosis.	0
Allele A in TNF-beta gene +252 site can significantly increase the relative risk of @DISEASE$ in women in Guangdong, among which TNF-beta @GENE$ genotype might be one of the genetic susceptible factors for endometriosis.	0
The results of this study provide evidence that variants in both the P1 and P2 promoters of @GENE$ increase risk for typical @DISEASE$.	1
The meta-analysis shows that the @GENE$ polymorphism is not a major risk factor for @DISEASE$, although a small effect or an enhancement of the APOE*4 effect cannot be excluded.	1
We conclude that  the @GENE$ locus is not related to the BP phenotype while expanded alleles at the CTG18.1 locus cannot be excluded as a vulnerability factor for BP @DISEASE$.	0
The C allele of -344C/T variant of @GENE$ increases susceptibility to @DISEASE$ in European men, but not in women, suggesting a pleiotropic role for this gene in modulating cardiovascular risk.	1
Our data implicate that the genotypic variation at codon 311 of @GENE$ contributes to the susceptibility of @DISEASE$ in the population of Taiwan.	1
Taken together, these results do not provide support for a role of the @GENE$ TaqI marker in our persistent @DISEASE$ samples.	1
We conclude that  (1) the variability in @GENE$ nasal NO levels are related to naturally occurring variants in the NOS1 gene, and (2) that nasal NOS1-derived NO affects the susceptibility of CF airways to @DISEASE$ with P. aeruginosa.	0
These results suggest that genetic variation in the @GENE$ gene contributes to increased @DISEASE$ and reveal a pathway leading to this common metabolic disorder in Japanese.	0
These findings suggest that @GENE$, tumor necrosis factor-alpha, epidermal growth factor receptor, and vitamin D receptor polymorphisms may be involved in the pathogenesis of @DISEASE$.	1
mutations in the gene encoding @GENE$ are not common in sporadic cases of @DISEASE$ and nonspecific interstitial pneumonia, suggesting that the mutated gene does not play an important role in the pathogenesis of these forms of idiopathic interstitial pneumonia.	0
The presence of the A1 allele of the @GENE$ gene is associated with a higher risk of @DISEASE$ in Spanish men.	1
These results suggest that polymorphisms within the @GENE$ gene may have implication in @DISEASE$ pathology shared by pure AD and LBV.	1
Together, our findings suggest that @GENE$ gene polymorphisms do not influence the susceptibility to MS or the clinical characteristics of @DISEASE$ in Japanese patients.	1
The results suggest a possible role of @GENE$ @DISEASE$ genotype as a predisposing factor to AF and a pathophysiological mechanism of ACE inhibition in reducing the incidence of AF in patients with left ventricular dysfunction.	0
These results suggest that the CC genotype of the @GENE$ intron 7 polymorphism is an independent protective factor for @DISEASE$, an effect probably mediated by increased TFPI levels.	1
These results suggest the involvement of the @GENE$ gene in @DISEASE$ of unknown etiology in adult patients.	1
We conclude that  this @DISEASE$ appears to be a frequent @GENE$ gene polymorphism causing no impaired function of the enzyme and no measurable dyslipidemia in the general population.	0
Mutated @GENE$ allele may be considered a favorable prognostic factor in @DISEASE$.	1
The @GENE$ Glu298-->Asp polymorphism may be related to early @DISEASE$.	0
This study does not provide strong evidence for further investigation into the role of the @GENE$ SNPs in @DISEASE$ progression.	1
@GENE$ may be a @DISEASE$-specific susceptibility loci, although only extensive examination of the whole HLA region in different inflammatory/AIDs will enable DR/DQ independent HLA effects to be determined.	0
These data suggest that genetic variants of @GENE$ and the bradykinin B(2)-R influence the @DISEASE$ pressure levels in patients with primary aldosteronism.	0
These findings suggest that @GENE$ may play a role in the @DISEASE$ of substance dependence and this role is population- and diagnosis-specific.	0
We conclude that  the strongest association between @GENE$ gene polymorphisms and @DISEASE$ susceptibility occurs with the 3' UTR polymorphism.	1
@GENE$-V64I was not associated with plasma or CSF @DISEASE$-1 RNA load, suggesting that the impact of CCR2 on neuropathogenesis may involve alterations in inflammatory responses within the CNS rather than a direct impact on viral entry or replication.	0
HLA-DR @GENE$*13, DR16, DQ2 and DQ5 may be associated with the @DISEASE$ and increase the risk of CAE.	0
None of the SNPs of KCNQ1 P448R, KCNQ1 R519H, KCNQ1 G643S, @GENE$ G38S and KCNE1 D85N was associated with atrial fibrillation phenotype, but KCNE4 E145D may relation to @DISEASE$.	1
Our findings support the hypothesis that genetically determined changes in @GENE$ metabolism regulation may contribute to the @DISEASE$ of schizophrenia confirming a role of IL-1 gene cluster in disease susceptibility.	0
The effects of @GENE$ gene polymorphism on calcium metabolism contribute to the understanding of the @DISEASE$ of urinary calculi.	0
These results indicate that variations in @GENE$ activity contributes to @DISEASE$ risk and the magnitude of the association may differ by ethnicity and be modified by meat consumption.	1
Our data on 2257 individuals implies that the @GENE$ intron 1 SNP is not a risk factor for @DISEASE$ aetiology of the knee or of the hip in our UK Caucasian sample.	1
a rare, novel mutation that disrupts a protein binding site in the pancreatic @GENE$ promoter associates with @DISEASE$.	1
@GENE$ DD genotype is related to endothelium-dependent arterial dilation in the early stage of @DISEASE$ and in healthy individuals.	1
These findings show that, unlike what has been consistently demonstrated in the general population, p53 mutations are uncommon in @DISEASE$ occurring in young patients, and in such patients, @GENE$ alterations are significantly associated with the cardiac location.	1
In summary, the frequency of the S20G @DISEASE$ in the @GENE$ gene is 1.92% in unrelated Korean type 2 diabetic patients and this mutation is associated with a lower BMI and a higher HbA(1c) level.	0
Our findings suggest that genetic variations of the @GENE$ gene can contribute to the enlargement of the lateral ventricles described in early phases of @DISEASE$.	1
We conclude that  variants in @GENE$ do not appear to be major determinants for type 2 diabetes in Pima Indians; however, HNF4alpha may have a minor role in @DISEASE$ susceptibility within this Native American population.	1
These findings suggest that @GENE$ or a nearby gene may contribute to the overall genetic risk for @DISEASE$.	1
In Japanese @DISEASE$, the +49A allele of CTLA-4 increased in the presence of SSc with the anti-@GENE$ antibody.	0
The increased allele sharing in the @GENE$ gene region on 19p13 is consistent with an important involvement of this region in @DISEASE$, especially migraine with aura.	1
TT genotype of @GENE$-1055 is not an independent factor for @DISEASE$ in Chinese Han people in Beijing, but increases the risk for smokers to develop COPD and the one who has COPD family history as well.	1
The @GENE$ gene is strongly associated with, and linked to @DISEASE$ in a Russian population.	1
The 10.5-kb homozygote of @GENE$ gene is associated with a prolonged survival in patients with @DISEASE$, as has been shown in the patients with lung cancer.	1
Given the fact that anti-CCP-negative RA differs from anti-CCP-positive RA with respect to genetic and environmental risk factor profiles, our results indicate that genetic variants of @GENE$ contribute to a unique disease etiology and pathogenesis in anti-CCP-negative @DISEASE$.	1
Thus the frequency of 6bINS differs between SSc patients with or without @GENE$, suggesting the implication of ENG in this devastating vascular @DISEASE$ of SSc.	0
These results indicate that mutations in NLGN3 and NLGN4 genes are responsible for at most a small fraction of autism cases and additional screenings in other autistic populations are needed to better determine the frequency with which mutations in NLGN3 and @GENE$ occur in @DISEASE$.	1
, these results do not confirm an independent relationship of tHcy and @GENE$ genotype with risk of @DISEASE$.	1
These data indicate that genetic variants in @GENE$ have pharmacogenetic effects influencing asthmatic response to corticosteroids, provide a rationale for predicting therapeutic response in asthma and other corticosteroid-treated @DISEASE$, and suggests this gene pathway as a potential novel therapeutic target.	0
Our results suggest that the Arg110Gln polymorphism of @GENE$ gene is associated with susceptibility of @DISEASE$ and elevated total plasma IgE in Chinese children of Han nationality in Hubei, but not with them in adults.	1
In this, to our knowledge, first association study based on children and adolescents with @DISEASE$, we confirm an association of the A-allele of the @GENE$ receptor gene with OCD.	1
The NADH/NADPH oxidase p22 phox gene is a susceptibility locus for @DISEASE$ in men, and the stromelysin-1 and @GENE$ genes are susceptibility loci in women.	1
@GENE$(*)0103 is associated with susceptibility to @DISEASE$, and IKBL+738(C) marks a propensity to extensive and more severe disease.	1
Our findings are the first to show that there is increased risk of @DISEASE$ in carriers of @GENE$ mutations and that the risk is related to genotype.	0
A significant association between HIV-1 infection and the presence of an allelic variant was observed in the case of the M2 and A332A haplotypes, thus presenting @GENE$ as a potentially novel @DISEASE$-1 susceptibility locus.	1
This @GENE$ study suggests that the CD14 -260 polymorphism is not associated with an increased risk of @DISEASE$ in trauma patients.	0
The results of the present study, which is much larger than previously published studies, provide no evidence that either CCR5-Delta32 or @GENE$-64I is associated with @DISEASE$.	0
These results suggest that wide variability in gene expression and functional polymorphisms in @GENE$ may explain part of the interindividual variations in @DISEASE$ and the analgesic efficacy of nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors; this may be useful to define individual responders on the basis of genetic variations to predict patient risk and benefit to drugs.	0
These results suggest that the natural history of cutaneous HPV 2/27/57-induced @DISEASE$ may be modulated by allele polymorphisms at the HLA-DQA1 and @GENE$ gene loci.	1
it is likely that @GENE$ gene does not have a major role in @DISEASE$ and CHD in our populations, although we can not exclude a minor contribution of the PPARalpha gene to the risk of CHD associated with Type 2 diabetes through a modulation of atherogenic plasma lipids.	0
our results confirm @GENE$ genotype data for Koreans and suggest that analysis of ABCB1 polymorphisms may have clinical relevance to prevent respiratory @DISEASE$ by intravenous fentanyl or to anticipate its clinical effects.	0
Based on these results, we conclude that homozygosity for the @GENE$ 2677T (S893) allele is associated with reduced risk of chronic renal @DISEASE$ among liver transplantation patients receiving an immunosuppressive regimen containing CNIs.	0
Val158Met polymorphism in @GENE$ gene could be a candidate for low penetrance @DISEASE$ susceptibility in Shanghai population, especially among premenopausal women and early-onset breast cancer patients.	1
The results of our study indicate that @GENE$ (A49G) exon 1 polymorphism is associated with @DISEASE$ progression.	1
In conclusion, our data suggest that the TT @GENE$ 677 genotype is associated with marked MTX-induced @DISEASE$ and could represent a pharmacogenetic marker for toxicity after chronic treatment with low doses of MTX.	0
Our results suggest that the @GENE$ 4G/5G promoter polymorphism is not associated @DISEASE$ risk factors or incident CVD events in the elderly.	1
We conclude that  the 3' VNTR and three additional promoter variants in @GENE$ do not appear to be associated with @DISEASE$, or response to stimulant mediation in our sample.	1
@GENE$ Arg753Gln polymorphism is possibly associated with CMV replication and @DISEASE$ after liver transplantation.	0
These data therefore confirm the importance of @GENE$ in @DISEASE$ susceptibility in humans and suggest that SLC11A1 influences tuberculosis susceptibility by regulation of interleukin-10.	1
Therefore, we have identified the first potentially functional polymorphism of @GENE$ and demonstrated its genetic association with a common human @DISEASE$, ulcerative colitis.	0
@GENE$ contributes to human @DISEASE$ and hence may be a target for subsequent functional analyses.	1
We conclude that  common genetic variation in TNFSF5 is not likely to affect @DISEASE$ susceptibility in West Africa and the linkage observed in this region is not due to variation in @GENE$.	1
Taken together, our results provide the first important evidence that the newly discovered 734Ile allele in @GENE$ might influence susceptibility to precocious @DISEASE$ in our population.	1
Our matched case-control and family study indicate that @GENE$, but not Cx40, may play a role in the genetic susceptibility to @DISEASE$.	1
Our data indicate that the severity of @DISEASE$, in terms of the number of diseased vessels, may be affected by common genetic variation in the @GENE$ gene cluster, on chromosome 7.	1
These results suggest that the @GENE$ genetic polymorphism modulates @DISEASE$ risk, especially in men and ever smokers.	1
Our data do not support a role of A986S CaR polymorphism in @GENE$ and in the prevalence of @DISEASE$ fractures in Italian postmenopausal women.	0
demonstrated that neither single marker nor haplotype analysis revealed an association between variants at the GRIP1 locus and @DISEASE$, suggesting that it is unlikely that the @GENE$ polymorphisms investigated play a substantial role in conferring susceptibility to schizophrenia.	1
Although rs7566605 was not significantly associated with obesity in our study population, we can not rule out the involvement of INSIG2 in @DISEASE$ related traits as we found significant association of another tagSNP in @GENE$ with both BMI and ABDCIR.	1
The results suggest that dysregulation of @GENE$-driven down-regulation of T-cell function due a genetic dimorphism in exon 1 may be involved in the @DISEASE$ of different MS disease subtypes.	0
Our results suggest that the @GENE$ gene polymorphism can serve as a useful genetic marker of increased susceptibility to @DISEASE$ and its renal complications.	1
Comparison of the genotypes of 242 GBS patients and 210 healthy subjects showed that polymorphisms in @GENE$ and TLR4 did not confer @DISEASE$ susceptibility and were not associated with C. jejuni infection.	0
We therefore concluded that the @GENE$ gene is unlikely to harbor variants that contribute to risk of @DISEASE$.	1
The @GENE$ deletion allele may protect against @DISEASE$ in the setting of obstructive sleep apnea.	1
Our data support the view that 192 R allele of @GENE$) gene is a risk factor for macrovascular @DISEASE$ of T2DM in Chinese.	0
Our data indicate that @GENE$ does not contribute substantially to susceptibility to @DISEASE$.	1
These results suggest that the polymorphism (-58 T/C) in the promoter region of BDKRB might be a risk factor and might have a synergetic effect with the @GENE$ for @DISEASE$ in hypertensives, but it is not associated with hypertension in the Japanese population.	0
In contrast to traditional coronary risk factors, the @GENE$ M/L mutation can be considered predictive of protection against @DISEASE$.	1
We revealed that there are significant ethnic differences in the C702T and G1612A allele frequencies, but suggested that C702T, C936T and G1612A polymorphisms in the 3'-@GENE$ of VEGF gene are not associated with the risk of @DISEASE$, at least in Japanese population.	0
In CAD subjects, a proportion of the risk of @DISEASE$ may be influenced by the interaction between smoking and a polymorphism in the antioxidant enzyme @GENE$.	1
@GENE$ gene polymorphisms were found to be an independent prognostic marker for patients with @DISEASE$.	1
Our findings suggest that longer triplet repeats in the 5'UTR of the @GENE$ gene confer vulnerability to @DISEASE$.	1
Thus, we have shown for the first time ever that @GENE$ gene alleles and their combinations with the polymorphic variants of the TNFA gene are associated with predisposition to @DISEASE$ and severity of this disease.	0
The risk of @DISEASE$ is not strongly associated with the I105V and A114V polymorphisms in the @GENE$ gene or with GSTM3 intron 6 polymorphism.	1
In conclusion, the determination of the @GENE$ genotype might be a powerful tool for the prognosis of patients with early @DISEASE$.	1
The @GENE$ deletion polymorphism does not play a major role in @DISEASE$ susceptibility as previously indicated.	1
@GENE$ is significantly overexpressed in the blood of @DISEASE$ patients but genetic variation within PADI4 is not a major risk factor for RA in Caucasians.	1
These findings suggest that genetic polymorphisms in @GENE$, PTGER3, PTGER4, PTGIR, and TBXA2R play important roles in the @DISEASE$ of aspirin-intolerant asthma.	0
The eNOS G894T or eNOS 894TT genotypes in combination with the @GENE$ 677TT or ACE D/D genotype increases the risk of @DISEASE$.	1
By analysis of a large number of subjects and a more specific patient selection, we showed the first genetic evidence that MTHFR C677T, @GENE$ A2756G and MTRR A66G genotypes were independently associated with @DISEASE$.	1
We conclude that  the distribution of @GENE$ gene polymorphism is similar in diabetic subjects and in general population and there is not association between I/D polymorphism and @DISEASE$ in type II diabetic patients.	0
We demonstrate that variation in the @GENE$ gene influences human left ventricular growth in response to exercise and @DISEASE$, indicating that maladaptive cardiac substrate utilization can play a causative role in the pathogenesis of LVH.	0
The results of our study of Turkish prostate cancer patients suggest that @DISEASE$ of the @GENE$ gene may be an important risk factor for prostate cancer.	0
These results provide strong evidence for pathogenic variant(s) in the 276-kb region harboring @GENE$ that influence intermediate @DISEASE$ phenotypes and risk for AD.	1
None of the SNPs of KCNQ1 P448R, KCNQ1 R519H, KCNQ1 G643S, @GENE$ G38S and KCNE1 D85N was associated with @DISEASE$ phenotype, but KCNE4 E145D may relation to atrial fibrillation.	1
Taken together, our results provide some additional support for the hypothesis that selected, rare @GENE$ mutations are associated with increased @DISEASE$ susceptibility among African-American men.	1
The study demonstrates that patients who develop @DISEASE$ while taking atorvastatin are more likely to experience a greater degree of muscle @GENE$ if they express two copies of CYP3A5*3.	0
Therefore, our results suggest that the @GENE$/CT60 polymorphism does not play a major role in inflammatory @DISEASE$.	0
Our study showed that gene polymorphisms of CYP1B1 and @GENE$ induce an individual susceptibility to @DISEASE$ among current smokers.	1
In conclusion, neither the BCHE K nor the @GENE$ C2 confers a risk for @DISEASE$.	1
Our findings in humans strongly indicate that the @GENE$ signaling system is implicated in @DISEASE$ regulation and suggest a new and unexpected functional role of a signal peptide.	0
Our results suggest that @GENE$ MspA1 polymorphism may be at best a @DISEASE$ modifier of breast cancer risk but is not a significant independent risk factor.	0
These results suggest that genetic variants of @GENE$ may play a role in the development of @DISEASE$.	0
Our results support previous epidemiological studies that @GENE$ may play a role in cigarette smoking-induced @DISEASE$.	0
The @GENE$ I555 (P568) allele is common in blacks and is associated with higher @DISEASE$ pressure and an increased risk for prevalent hypertension.	0
The presence of the @GENE$ epsilon4 allele is associated with an increased risk of @DISEASE$ and a more rapid rate of cognitive decline in old age.	0
This study suggests a putative role of the @GENE$ gene polymorphism at position 49 of exon 1 for @DISEASE$ in the Korean population, although the detailed mechanisms remained to be elucidated.	1
Our findings suggest that this @GENE$ promoter polymorphism influences @DISEASE$ neuropathogenesis by regulating MCP-1 protein expression in the central nervous system (CNS).	1
We conclude that  long @GENE$ 3' VNTR alleles occur more frequently in @DISEASE$ patients, but that apoB 3'VNTR genotypic variation has little impact on the risk of dyslipidemia in Taiwanese.	1
@GENE$ contributes little, if at all, to the development of @DISEASE$ in southern India.	0
In conclusion, these data suggest that the G331A polymorphism in the @GENE$ gene may influence the risk for @DISEASE$ in women.	1
The result suggests that the c.-469delG and possibly other variants of the @GENE$ gene may be of relevance to the complex factors involved in the pathogenesis of @DISEASE$.	1
The significance of the G(-930)A polymorphism of @GENE$ was confirmed in the present study with adequate statistical power, which strengthens the hypothesis that this polymorphism is important in the @DISEASE$ of hypertension and confers susceptibility.	0
In Taiwanese children sensitized to Der f, the @GENE$(+)/LTalphaNcoI*1 haplotype was associated with a much higher risk of having clinical @DISEASE$ than any other DR13/LTalphaNcoI haplotype.	0
The C allele of the @GENE$ gene increases the risk of developing @DISEASE$.	1
it is unlikely that common variants in MLH1, @GENE$, PMS1, MSH2, MSH3 and MSH6 contribute significantly to @DISEASE$ susceptibility.	1
Our data suggest that the presence of the -420C/G SNP of the @GENE$ gene is associated with increased @DISEASE$ and metabolic syndrome, although it is not different in subjects at high cardiovascular risk such as patients with myocardial infarction or patients with renal dysfunction compared with controls.	0
These results suggest that @GENE$ lsehara-1 is a new genetic risk factor for ischemic @DISEASE$, especially lacunar-type infarction, in Japan.	0
Therefore, VLBW neonates with (1267)GG might express less @GENE$ and might be less protected against @DISEASE$.	0
linkage of the human @GENE$ gene to @DISEASE$ in a subset of patients supports a pathogenic role of nitric oxide in human IDDM.	1
@GENE$ variants may be a possible factor influencing the prophylactic efficacy of lithium in @DISEASE$.	1
A novel VNTR polymorphism in @GENE$ exists in Chinese population and is not associated with @DISEASE$ risk.	1
Genetic variation within the @GENE$ promoter region was associated with cap thickness and therefore may influence the role of MMP2 in @DISEASE$ vulnerability.	0
@GENE$ 192R+ genotypes were associated with @DISEASE$ and MI, particularly in subsets of patients, in patterns suggesting a possible survivor effect.	0
Our present data suggest that the MMP-1 and @GENE$ promoter polymorphisms may be associated with a @DISEASE$ susceptibility in Japanese.	1
These results suggest that the @GENE$ gene appears to be involved in development of more aggressive phenotype of @DISEASE$.	1
The @GENE$ gene is related to @DISEASE$, liability to side effects of antipsychotic medication, and movement disorders and may therefore have important clinical implications for ASD.	0
Although we could not find any association between genetic variability in exon 3 and 4 of @GENE$ and pre-eclampsia, genetic variability in these two exons jointly modifies the predicted enzyme activity and may be a risk factor for @DISEASE$.	1
The C allele at the T(-786)C @GENE$ polymorphism is associated with a higher risk of multivessel @DISEASE$ in Caucasians.	1
These data suggest a role for apoA-IV in fat storage or mobilization and that genetic variations in the @GENE$ gene may play a role in the development of @DISEASE$.	1
These results suggest that the polymorphism of @GENE$ acts as a genetic factor for the development of smoking-induced @DISEASE$.	1
Our data confirm that, independent of transcriptional activity, the C(-444) allele in the @GENE$ gene is weakly associated with the @DISEASE$ phenotype, but it is not related to disease severity or aspirin intolerance.	0
These results suggested that the Gln-Arg192 polymorphism of the @GENE$ gene was not associated with @DISEASE$ in Chinese population.	1
The association of longer @GENE$ CAG with @DISEASE$ and leptin suggests that shorter AR CAG may have an influence in maintaining healthy anthropomorphics and metabolism in men with DM2.	0
In conclusion, no correlation was found between @GENE$ exon 1 (+49) and promoter (-318) polymorphisms and @DISEASE$ in our study.	1
These findings provide replication of the association between @DISEASE$ and @GENE$.	1
These results suggest that @GENE$ 16 locus genetic polymorphism is correlated with @DISEASE$ severity in the people of the Han nationality of northern China.	1
Genetic variability in @GENE$ is not associated with dominant Type I diabetes, MODY, @DISEASE$ or changes in insulin secretion in the Danish Caucasians examined subjects.	1
@GENE$ mutations, especially those with a haplotype consisting of 2729A>C and A455V missense mutation, affect sTM levels, and may be associated with @DISEASE$ in Japanese.	1
This study is the first to identify a possible association between @GENE$*0404 and VKH @DISEASE$, as well as to find DRB1*0102 and DRB1*0410 in Mestizo patients.	0
MMP-2 -1306T/C and @GENE$ -1562C/T polymorphisms may be associated with genetic susceptibility to @DISEASE$.	1
@GENE$ polymorphisms may function as a common genetic factor in clinically distinct @DISEASE$ involving bronchial smooth muscle contraction and inflammation.	0
@GENE$ D356N heterozygotes were found to have an increased risk of @DISEASE$ among whites (odds ratio, 1.	1
These results suggest that @GENE$ and transferrin may be part of a complex mechanism in the @DISEASE$ of Alzheimer's disease.	0
Our results suggest that the COX-2 Val511Ala SNP does not antagonize the effect of NSAIDs on @DISEASE$ risk and provides support that NSAID use and the @GENE$ Val511Ala SNP may contribute to a reduced risk of colon cancer among African Americans.	1
Our study failed to demonstrate an association between either the -429T/C or the -374T/A gene polymorphism of the @GENE$ gene and @DISEASE$ in the Slovene population with type 2 diabetes of duration longer than 10 years.	1
men with a short CAG repeat in the @GENE$ gene have an increased risk of developing @DISEASE$.	1
We found no association between @GENE$ and TLR4 polymorphisms and invasive @DISEASE$.	0
@GENE$ * A6 allele may be associated with AD negatively in Shanghai area, and this effect only exists in non-ApoE * epsilon 4 @DISEASE$.	1
we found no evidence for a common contribution of @GENE$ to the @DISEASE$ of complex inherited MA.	0
Our results indicate that the T allele in the @GENE$ promoter is associated with the invasive phenotype of @DISEASE$.	1
Using logistic @DISEASE$ and multiple correlation analysis (MCA), we confirmed that the main risk factor associated and consistently grouped with AD patients in this population is APOE4, but this association was not observed with alleles and genotypes of @GENE$ and A2M.	0
These results show no evidence of an association between the MAOA-uVNTR polymorphism and completed suicides and suggest that @GENE$ is not involved in the susceptibility to @DISEASE$.	1
We therefore conclude that the E469K polymorphism of @GENE$ is not a risk factor for @DISEASE$ or PD.	1
The A allele was associated with increased @GENE$ and was protective against a common form of @DISEASE$, suggesting that RUNX2 variants may be related to genetic effects on BMD and osteoporosis.	0
Therefore, our findings suggest that the novel promoter polymorphism of the @GENE$ gene may influence susceptibility to @DISEASE$ in the Japanese population.	1
We conclude that  there are @GENE$ host-dependent differences in MMP-9 promoter activity related to CA-repeat number and that fetal carriage of the 14 CA-repeat allele is associated with @DISEASE$ in African Americans.	0
These findings suggest that @GENE$ may be related to the cognitive decline observed in AD patients and that apoD and apoE likely play different roles in the pathogenesis of @DISEASE$.	1
A previously studied sequence change of the regulatory region of the @GENE$ gene, the same as has previously been associated with low BMD in many populations and LDD in older adults, showed a strong association with LDD in young male soldiers who were recently diagnosed with this @DISEASE$.	0
This suggests that there is no direct association of this @GENE$ gene variant with @DISEASE$ susceptibility.	1
We observed that the four polymorphisms in the promoter region of the @GENE$ gene were not associated with @DISEASE$ or coronary artery disease in Koreans.	0
Our findings suggest that @GENE$ or a gene nearby may contribute to the overall genetic risk for @DISEASE$ among Japanese.	1
It is concluded that T-->C polymorphism of @GENE$ gene is not associated with steroid hormone synthesis in PCOS and is not the primary genetic @DISEASE$ in this disease.	0
This study provides some support for polymorphic variation in CYP1A2 and @GENE$ playing a role in @DISEASE$ susceptibility.	1
we propose the @GENE$ as a new susceptibility gene for @DISEASE$.	1
It is therefore unlikely that the @GENE$ Val 145 Ile variant is responsible for genetic susceptibility to @DISEASE$.	1
In conclusion, we have demonstrated that the CAG repeat polymorphism in the first exon of the @GENE$ gene is associated with reduced bone mass and increased risk of @DISEASE$ in women.	0
These results suggested that -58C allele of the human @GENE$ bradykinin receptor gene may be an independent risk factor for @DISEASE$ in the Chinese Han population.	0
5alpha-Reductase @GENE$ 2 gene @DISEASE$ do not constitute a major factor in the development of cryptorchidism or idiopathic azoospermia.	0
Future studies are needed to examine the mechanism underlying the association between the @GENE$ epsilon4 allele and Se levels, including the role of @DISEASE$ and that of reduced lipid metabolism in the apoE epsilon4 carriers.	0
the CPSI T1405N genotype appears to be an important new factor in predicting susceptibility to increased @GENE$ following surgical repair of congenital @DISEASE$ in children.	0
In the present study, neither the MCP-1 (-2518) G allele itself nor its interaction with the @GENE$ (-889) allele 2, TNF-alpha (-850) allele T or APOE epsilon4 allele conferred increased risk for @DISEASE$.	0
the analysis of a very large data set suggests that genetic polymorphisms in @GENE$ may influence @DISEASE$ severity and supports the possibility that viral factors may contribute to the clinical course of MS, consistent with previous reports.	1
genomic variations of @GENE$ are not likely to be substantially involved in the etiology of @DISEASE$.	1
the A1513C polymorphism in the P2X7R gene is related to the occurrence of @DISEASE$ and survival after allogeneic stem @GENE$ transplantation.	0
In conclusion, the ADPRT Val762Ala polymorphism plays an important role in smoking-related @DISEASE$ and the @GENE$ Arg399Gln polymorphism may serve as a risk modifier.	1
Early age at onset may be a good predictor of @GENE$ mutation in Liguria, where the G101W founder mutation is prevalent among @DISEASE$ patients, independent of family history.	1
These results suggest that the Arg(972) @GENE$ variant could contribute to the risk for atherosclerotic @DISEASE$ associated with type 2 diabetes by producing a cluster of insulin resistance-related metabolic abnormalities.	1
These findings suggest that the change of C to G at position -9 of the @GENE$ gene is associated with the insulin resistance of @DISEASE$ due possibly to a potentiated hydrolysis of the PI3-kinase product.	1
We found genetic variants in @GENE$ and XRCC1 may alter the risk of @DISEASE$ in a special population in China.	1
Our study showed that gene polymorphisms of CYP1B1 and @GENE$ induce an individual susceptibility to @DISEASE$ among current smokers.	1
This study provides some support for polymorphic variation in @GENE$ and CYP1B1 playing a role in @DISEASE$ susceptibility.	1
Our results suggest @GENE$ and TIMP-2 genotypes play a crucial role in gastric cancer @DISEASE$, but not with development of gastric cancer.	0
This confirms our prediction and represents an additional level of correlation between thymic @GENE$ and @DISEASE$ susceptibility, which supports a thymic enhancer effect of the INS variable number of tandem repeats as the mechanism of IDDM2 and refines the contribution of IDDM2 genotyping to diabetes risk assessment.	0
Genetic variation in MYO9B does not have a major effect on @DISEASE$ susceptibility in the @GENE$ population.	0
It appears that the C242T polymorphism of @GENE$ is not associated with the incidence of @DISEASE$ in the Japanese population.	0
The common Val16Ala MnSOD polymorphism and C-T substitution in the promoter region of the @GENE$ gene do not confer increased or reduced risk of @DISEASE$ in Chinese in Hong Kong.	0
The data suggest that the @GENE$ 213PP genotype is a genetic risk factor for the development of @DISEASE$ in type 2 diabetes mellitus.	0
In conclusion, the @GENE$ Val762Ala polymorphism plays an important role in smoking-related @DISEASE$ and the XRCC1 Arg399Gln polymorphism may serve as a risk modifier.	1
Our results suggest that the @GENE$ Val511Ala SNP does not antagonize the effect of NSAIDs on @DISEASE$ risk and provides support that NSAID use and the COX-2 Val511Ala SNP may contribute to a reduced risk of colon cancer among African Americans.	1
The @GENE$ gene may, therefore, be a susceptibility gene in some @DISEASE$ patients, further supporting the epidermal oxidative stress model for vitiligo pathogenesis.	1
Together, psoriasis is not associated with a promoter polymorphism in the @GENE$ gene nor with the production of IL-12p70 by LPS-stimulated @DISEASE$ cells.	0
Our results suggest an @GENE$ of the B2BKR polymorphism on LV mass @DISEASE$ during antihypertensive treatment.	0
The frequency of INSL3/@GENE$ gene mutations as a cause of @DISEASE$ is low, because only 2 of 145 (1.4%) formerly cryptorchid patients were found to have mutations.	1
These findings suggest that @GENE$ -159C/T polymorphism is not related to the development of periodontitis in a Japanese population, but that, within the periodontitis subjects, expression of the SNP may be related to early @DISEASE$ activity.	0
We conclude that  the @GENE$ L10P polymorphism is not associated with @DISEASE$ risk.	1
the A(431) variant identified here is the major @GENE$ allele in Caucasians (with over 75% being A(431) homozygotes) but that this polymorphism is not a marker for @DISEASE$ susceptibility in the patients we have studied.	1
Our results provide evidence that the two truncating mutations of @GENE$ confer a moderate risk of @DISEASE$ in Polish men and that the missense change appears to confer a modest risk.	1
This study suggest that @GENE$-PAT polymorphisms may contribute to the risk of @DISEASE$ in our study population.	1
In conclusion, the Ala45Thr polymorphism contributes to the risk of development of, and to the early deterioration of beta-@GENE$ function, in Type 1a @DISEASE$ among the Japanese population.	0
A potential role for @GENE$ specific to systemic acquisition and dissemination of @DISEASE$ is suggested.	0
An association between this @GENE$ gene polymorphism and @DISEASE$ supports the notion that cell adhesion molecules are involved in the etiology of schizophrenia.	1
@GENE$ and BRCA2 mutations are common (9%) among unselected young @DISEASE$ patients undergoing BCT.	0
Common polymorphisms in the genes @GENE$ and LOC387715 are independently related to AMD @DISEASE$ after adjustment for other known AMD risk factors.	0
Our findings with this particular sample do not support the @GENE$ locus as a major susceptibility locus contributing to @DISEASE$.	1
This study suggests that the presence of the 192Arg-allele in the @GENE$ gene is a genetic risk factor for @DISEASE$ in Type 2 diabetes mellitus.	0
C-->T polymorphism of @GENE$ gene was considered as one of the possible susceptible genes, which specifically increased the risk of tobacco-related but CagA negative types of intestinal @DISEASE$ and stomach cardia cancer.	1
These results demonstrate that a polymorphism within the @GENE$ gene, probably through its effect on TS expression levels, can influence the survival benefit obtained by @DISEASE$ patients from 5-FU-based chemotherapy.	0
Our findings indicate that @GENE$ gene may be a candidate susceptibility gene for @DISEASE$ in Chinese Han population, and also provide further support for the potential importance of NMDAR-mediated glutamatergic transmission in the etiology of schizophrenia.	1
These findings suggest that genomic variations in the @GENE$ gene may confer susceptibility to @DISEASE$.	0
Taken together, our results provide some additional support for the hypothesis that selected, rare @GENE$ mutations are associated with increased @DISEASE$ susceptibility among African-American men.	1
These results suggest that hOGG1 may have a role in the repair of 8-OH-dG adducts in prostate tissue and @GENE$ Ser326Cys polymorphism is associated with @DISEASE$ risk.	1
These results suggest that variation in @GENE$ may be an important determinant of @DISEASE$ in humans and that the phosphate metabolism pathway may provide a novel target for the prevention and treatment of osteoporosis.	0
We conclude that  the @GENE$ gene is a significant, independent risk factor for @DISEASE$ in whites, but not in blacks, and may play a particularly important role for subjects with certain constellations of other risk factors.	1
The presence of the 4G allele of the 4G/5G polymorphism of the @GENE$ gene may be an additional risk factor for the development of @DISEASE$ in APS.	0
In our population the @GENE$ epsilon4 allele and the -491 A/T APOE promoter polymorphism are not associated with a more rapid course of @DISEASE$.	1
These findings suggest a possible role for @GENE$ polymorphisms in estrogen levels and in vasomotor @DISEASE$ during the menopausal transition that warrants further study in larger and more diverse populations of women.	0
The observation that CYP3A4 and CYP3A43 were associated with prostate cancer, are not in linkage equilibrium, and are both involved in testosterone metabolism, suggest that both @GENE$*1B and CYP3A43*3 may influence the probability of having @DISEASE$ and disease severity.	1
These results suggest that the Gln223Arg variant in the maternal @GENE$ gene does not explain the association between placental leptin levels and birth weight, and is not associated with variation in maternal BMI in @DISEASE$ in our sample.	0
Thus, in addition to the antigen-driven excess Th2 response, increased @GENE$ (and subsequent IFN-gamma) production in human airways of individuals with the -1993T-->C polymorphism could contribute to the development of certain @DISEASE$-related phenotypes, such as AIA.	1
Our data modestly support a protective effect of the @GENE$-e4 allele on AMD risk, but emphasize the need to investigate more thoroughly whether the effect could be restricted to cases with a family history of @DISEASE$ and whether it varies across age and sex groups.	1
These results suggested that the CTLA-4 gene might be involved in the susceptibility to RA in the Chinese Han population and both +49 and CT60 of @GENE$ gene might be the causal variants in @DISEASE$ disease.	1
The C/T polymorphism of the KLK2 gene and circulating levels of @GENE$ are correlated and, in combination, are highly predictive for @DISEASE$.	1
In this study, we identified SNPs in @GENE$, ERCC2, and CYP2D6 genes as putative markers to predict individuals at risk for complications arising from radiation therapy in @DISEASE$.	1
SNPs identified in @GENE$ gene expression regulators CAR, HNF4alpha, and PXR in the Asian @DISEASE$ population do not seem to have any significant effect on the clearance of docetaxel, a CYP3A substrate.	0
The @GENE$ gene codon 72 polymorphism may play a role in susceptibility to @DISEASE$.	1
The @GENE$ polymorphisms studied are not implicated in susceptibility to @DISEASE$ and do not predict sVEGF levels.	1
In conclusion, these findings suggest that @GENE$ mutations in smokers with @DISEASE$ may be due in part to accumulation of carcinogens, which is not adequately detoxified in individuals with certain CYP1A1 genotypes and the GSTM1(-) genotype.	0
@GENE$ * A6 allele may be associated with @DISEASE$ negatively in Shanghai area, and this effect only exists in non-ApoE * epsilon 4 AD.	1
These results do not suggest a major role of the short variant of @GENE$ in susceptibility to @DISEASE$, but provide modest evidence for an effect on seasonality.	1
As SNPs in @GENE$ increase risk for both inflammatory bowel disease and @DISEASE$, this suggests a common pathway in the pathogenesis of these diseases.	1
Replication of the original @GENE$ findings in these 4 additional asthma populations suggests that this gene (and perhaps others that interact with it) is important in the development and pathogenesis of @DISEASE$.	1
These data suggest that common variation in @GENE$ significantly influences plasma lipid levels and the severity of @DISEASE$.	1
The high activity allele of the @GENE$ gene may represent a modifying factor involved in the severity of @DISEASE$ manifestations in females.	1
our data suggest that the @GENE$ rs6232 and rs6235 SNPs are not major contributors to common @DISEASE$ in the general population.	1
The association found between TLR4 genotype and risk of MI suggests that @GENE$ genetic variants could potentially affect the susceptibility to @DISEASE$ and that TLR4-mediated innate immunity is implicated in the pathogenesis of MI.	1
This report of an association with a polymorphic site within the @GENE$ locus and AS suggests that genes other than B27 may well be involved in the @DISEASE$ of AS.	0
This study failed to confirm an earlier report of a potential role of a @GENE$ polymorphism in the @DISEASE$ of delirium tremens.	0
Carriage of @GENE$ H2 haplotype does not seem to affect the platelet response to a 600 mg loading dose of clopidogrel in @DISEASE$ patients prior to stenting.	0
We conclude from this large prospective study that the G allele of SNP43 of @GENE$ or another allele or gene that is in linkage disequilibrium with it increases susceptibility to @DISEASE$ in African-Americans.	1
The -56T allele in the @GENE$ promoter results in higher IFNGR1 transcriptional activity and represents a genetic risk factor for @DISEASE$ cataracts.	0
The results suggested that both @GENE$ and apoCI on chromosome 19 were the susceptibility locus for CAD, their linkage disequilibrium should be responsible for the development of @DISEASE$.	1
The presence of the R1141X @DISEASE$ in the @GENE$ gene is associated with a sharply increased risk of premature CAD.	0
The @GENE$ haplotype that is associated with AAD in Caucasians appears to be protective for @DISEASE$ in the Japanese population, demonstrating that this haplotype is unlikely to contain a single primary etiological allele for autoimmunity.	0
The @GENE$ DD genotype is associated with the development of incipient diabetic nephropathy and established @DISEASE$ in a Mexican population.	1
Our findings imply that @GENE$ germline polymorphisms are associated with @DISEASE$ disease behavior in the cohort examined.	0
Thus, the donor genotype for the @GENE$ polymorphism has an apparent protective role against @DISEASE$ following transplantation and may be an additional factor for individual risk assessment for complications, including GvHD, post transplant.	0
The rs1800947 SNP and the @GENE$-C haplotype in the CRP gene appear to be prognostic markers of @DISEASE$ and this polymorphism could be a useful genetic marker.	0
Thus, the more common @GENE$ promoter G allele, while being conducive for @DISEASE$, affords relative protection against type 2 diabetes.	0
We conclude that  the @GENE$ gene may be a genetic factor that influences the variability in age-at-onset of @DISEASE$.	1
Here we report that polymorphisms within the @GENE$ promoter, ACE1 and CYP46 gene are not risk factors for @DISEASE$ and are not associated with parenchymal or vascular accumulation of Abeta.	1
The results of this study suggest that the 184Ile homozygote of the @GENE$ gene may represent an important susceptibility biomarker for @DISEASE$ risk.	1
The result suggests that the c.-469delG and possibly other variants of the @GENE$ gene may be of relevance to the complex factors involved in the @DISEASE$ of schizophrenia.	0
The range of @DISEASE$ associated with mutations of the @GENE$ gene may be much greater than previously thought.	1
BRCA1 and @GENE$ mutations are common (9%) among unselected young @DISEASE$ patients undergoing BCT.	1
There is no evidence from this study that mutations in @GENE$, which lead to an altered protein, contribute to @DISEASE$ susceptibility.	1
These data show that trp catabolism is genetically controlled by the @GENE$ gene and may thus be operative in those @DISEASE$ conditions associated with the polymorphisms of the IFN-gamma gene.	0
@GENE$ is probably one of several genes that determine susceptibility to @DISEASE$.	1
We found that the @GENE$ genotype affects diazepam pharmacokinetics and emergence from general @DISEASE$ and that the slow-emergence group possesses lower levels of CYP3A4 mRNA than are found in the rapid-emergence group.	0
our family-based association study gives mild but further support of the involvement of @GENE$ variants in @DISEASE$.	1
These findings suggest that individual susceptibility to @DISEASE$ may be modulated by GSTM1, GSTT1 and @GENE$ polymorphisms.	1
it is unlikely that common variants in MLH1, MLH3, PMS1, MSH2, @GENE$ and MSH6 contribute significantly to @DISEASE$ susceptibility.	1
For patients with @DISEASE$ caused by systolic function, the Asp298 variant of @GENE$ is associated with poorer event-free survival, particularly in patients with nonischemic cardiomyopathy.	1
The @GENE$ polymorphism was not found to be associated with an increased risk of @DISEASE$, either overall or in selected subgroups, which were patients with premature disease onset (age < or = 60 years), first acute myocardial infarction, and patients who were men, women, and exclusively Caucasian.	0
Although @GENE$ does not seem to be implicated in the early @DISEASE$ of the disease, patients possessing the epsilon4 allele might have a reduced capacity for neuronal remodelling after relapses.	0
Our results suggest that @GENE$ intronic polymorphism may be associated with the severity of @DISEASE$ in the elderly.	0
Our results suggest that the C allele of the @GENE$ polymorphism is significantly associated with increased prostate cancer risk and clinically advanced @DISEASE$ in African Americans.	0
Functional variants of @GENE$ -260C/T, TNF-alpha -308G/A, and IL-6 -174G/C, implicated in the susceptibility to infection, are unlikely to confer major risk for susceptibility to @DISEASE$ and its progression or response to therapy in the LCAS population.	1
The combination of glutathione-S transferase M1 genotype 0/0 and @GENE$ mutant allele (-15621) is a risk factor for @DISEASE$ (OR-7.7).	1
The role of the @GENE$ genotype as a predictor of toxicity in @DISEASE$ patients receiving irinotecan demands the performance of a randomized trial to ascertain whether genotype-adjusted dosages of the drug can help to establish safe and effective doses not only for patients with the UGT1A1(*)28 homozygous genotype but also for those with the most common UGT1A1 6/6 or 6/7 genotype.	0
our results do not support a major role for @GENE$ gene promoter variants in @DISEASE$.	0
These results do not support @GENE$ 3111C as a marker for diurnal preference, tau, or @DISEASE$ in humans.	0
Our findings suggest that the @GENE$ polymorphism may impact on @DISEASE$, and one potential mechanism for this would be by influencing the generation of endogenous neurotransmitters in the brain.	0
The @GENE$ gene rs 2305764 polymorphism is not associated to @DISEASE$ in coeliac children from Southern Italy.	1
These findings provide initial evidence that environmental risks as described by the Rutter Family Adversity Index moderate the impact of the DAT1 gene on @DISEASE$ symptoms, suggesting a @GENE$ effect only in those individuals exposed to psychosocial adversity.	1
The Val66Met polymorphism of the @GENE$ gene is unrelated to the development or clinical features of @DISEASE$, at least in a Japanese population.	1
Our results do not support the suggested association of @GENE$ IVS1 -27G>A germline polymorphism with @DISEASE$ risk and also suggest that the variant is not a risk allele for BPH in the Finnish population.	0
Our results suggest that the common Leu84Phe and Ile143Val polymorphisms in @GENE$ influence risk of @DISEASE$ in women possibly through modulating estrogen receptor-dependent transcriptional activation, which has previously been shown to occur in response to DNA alkylation damage.	1
The present study fails to demonstrate that the genetic polymorphisms of MAOA-VNTR and @GENE$-A218C affect the antidepressant effect of fluvoxamine in Japanese patients with @DISEASE$.	1
These results provide evidence that the presence of common variants in the @GENE$ gene, may confer an altered cellular phenotype, and that the ATM 3161C>G variant might be associated with @DISEASE$ risk.	1
This finding supports the proposal that @GENE$ genotypes may modify individual @DISEASE$ risk.	1
Our findings suggest that the Aurora-A polymorphism contributes to a significantly earlier age at diagnosis of pancreatic cancer, and that Aurora-A and @GENE$ C580T polymorphisms synergistically contribute to an earlier age at diagnosis of @DISEASE$.	1
We conclude that  variations of the @GENE$ gene, or of a nearby gene, that may be in linkage disequilibrium with these alleles play a role in the development of @DISEASE$ in the UAEs.	0
In conclusion, the 27-bp repeat polymorphism of the @GENE$ gene was not associated with @DISEASE$ and the occurrence of AMI or unstable angina in a hospital-based Taiwanese population.	1
The CYP1A1 Ile-Val gene polymorphisms might be associated with the occurrence of prostate cancer, while MspI gene polymorphisms and @GENE$ slow acetylator genotype might not be associated with the occurrence of @DISEASE$.	1
Our study implies that it is possible that the G/C polymorphism of the @GENE$ gene may not be directly involved in the development and/or progression of @DISEASE$ but further researches, conducted on larger population, are needed to clarify this point.	1
This study showed that the @GENE$-251*A allele could be related to the development of distal @DISEASE$ in this Mexican population.	1
the functional @GENE$ gene polymorphism is not of major importance to @DISEASE$ in the European populations investigated.	1
The results suggest that dysregulation of @GENE$-driven down-regulation of T-cell function due a genetic dimorphism in exon 1 may be involved in the pathogenesis of different @DISEASE$ disease subtypes.	1
This study provides genetic evidence linking @GENE$ with @DISEASE$ in humans.	0
Our results confirm the positive association between @GENE$ gene and @DISEASE$ and indicate that CHL1 may be involved in the etiology of schizophrenia.	1
The 77C-->G transition in exon 4 of the @GENE$ gene may contribute to MS susceptibility only in very few families, if at all, but it is not relevant for the majority of @DISEASE$ cases, including virtually all German patients.	1
This indicates that the @GENE$ may be involved in the polygenic etiology of @DISEASE$.	1
Further studies will be needed to understand the different roles that @GENE$ polymorphisms play in susceptibility to @DISEASE$ in Caucasians and African Americans.	1
The results suggest that @GENE$ polymorphisms may contribute to @DISEASE$ risk among Han Chinese.	1
The @DISEASE$ of these mutations in @GENE$ patients might indicate that EVER 1 alleles are not associated with susceptibility to RRP, or that other, as yet unidentified, mutations in the Epidermodysplasia verruciformis 1 gene, might account for the susceptibility to RRP.	0
These results suggest that the human Gln-Arg 192 Q/R polymorphism of the @GENE$ gene is not associated with @DISEASE$ in an Italian population.	1
To conclude, our results support the hypothesis that Gln223Arg polymorphism of @GENE$ in Mexican adolescents is associated with haemodynamic and metabolic disturbances related to @DISEASE$.	1
we report an association of microsatelite @GENE$ polymorphisms of TLR2 gene and Asp299Gly polymorphism of the TLR4 gene with sporadic @DISEASE$ among Croatians.	0
The HLA-DRB1*0803 allele alone, the @GENE$*0803, DQA1*0103, DQB1*0601 haplotype, or both were negatively associated with @DISEASE$ to Bunashimeji, and these alleles might be involved in the prevention of Bunashimeji mushroom-specific respiratory allergy.	1
Smoking and having the @GENE$ CC genotype independently increase risk of neovascular @DISEASE$.	1
The results supported our previous data, and suggest the possible involvement of the -333G>T and the -286A>G polymorphisms in the promoter region of the @GENE$ gene in the predisposition to @DISEASE$.	1
Notably, the associations and the partitioned linkage profiles near @GENE$ were independently observed in a Finnish sample, suggesting the presence of potential regulatory element(s) that may contribute to the risk for @DISEASE$.	0
These results suggest that the @GENE$ polymorphism is associated with early onset of @DISEASE$ and contributes to susceptibility to SCCHN in this population.	0
@GENE$ genetic variations are associated with risk factors, severity, type and prognosis of stroke and @DISEASE$.	0
The G9943T @DISEASE$ in the plasma @GENE$ gene is not associated with premature CAD in Turkish subjects.	0
There is a synergy of susceptible genotypes GSTM1 0/0 and @GENE$ Val/Val or CYP1A1 Ile/Val to enhance the individual susceptibility to @DISEASE$.	1
To the authors' knowledge, this study provides the first evidence that biallelic @DISEASE$ of the @GENE$ gene may contribute to the development of HCC in patients with FAP.	0
The @GENE$ N34S variant is associated with @DISEASE$.	0
Our results suggest that @GENE$ and ACE genotypes may be independent risk factors for late-onset @DISEASE$, but the ACE association needs to be confirmed in independent samples in which the time and extent of vascular cofactors can be assessed.	0
Pathogenic roles of genotypic combinations of specific HLA-DQ haplotypes in a homozygous manner are suggested as causative mechanisms of @DISEASE$ beta-@GENE$ damage in a subtype of autoantibody-negative type 1 diabetes with fulminant clinical features.	0
We conclude that  the @GENE$-uVNTR regulatory polymorphism may contribute, in part, to individual differences in both CNS serotonergic responsivity and @DISEASE$ traits germane to impulse control and antagonistic behavior.	0
our @GENE$ analysis did not reveal any association between @DISEASE$ in our Han Chinese population and the CHRNA7 gene or its partially duplicated region.	0
We conclude that  the analyzed SNPs in GAL and @GENE$ do not play a major role in early onset obesity or dietary fat intake in the @DISEASE$ children and adolescents of our study groups.	1
@GENE$ variated genotype was one of the risk factors of cardia @DISEASE$ while different risks of factors might exsit between cardia and non-cardia gastric cancer.	0
These results suggest that, in a French Canadian @DISEASE$ population, @GENE$ may increase not only risk for obesity, as demonstrated in other populations, but also for hypertension.	0
The findings suggest that a TFAM haplotype containing rs1937 G (for @GENE$) may be a moderate risk factor for @DISEASE$.	0
The C allele at the UCSNP45 locus in @GENE$ is associated with @DISEASE$, and UCSNP43 influences the hirsutism score.	0
Using logistic regression and multiple correlation analysis (MCA), we confirmed that the main risk factor associated and consistently grouped with @DISEASE$ patients in this population is APOE4, but this association was not observed with alleles and genotypes of ACE and @GENE$.	1
These results provide further evidence that @GENE$ is important in the predisposition to UC, there may be genetic or pathogenetic heterogeneity between different ethnic groups, and UC and CD are genetically distinct @DISEASE$.	0
Our results support the involvement of @GENE$ as a susceptibility gene for @DISEASE$ in the Chinese population.	1
the @GENE$ intron 19-bp @DISEASE$ allele may be a protective NTD genetic factor by increasing DHFR mRNA levels in pregnant women.	0
These data suggest that 72Met carrier status may be used as a marker predicting a lower chance of developing renal @DISEASE$ in @GENE$.	0
These data together with recent functional data on the direct effect of @GENE$ on blood pressure suggest that the leptin gene and its product, leptin, are an attractive target for studies on the mechanisms of hypertension and for the development of methods for the prediction, prevention, and therapy for @DISEASE$.	1
The results suggest that a gene x gene interaction between @GENE$ and DRD4 is associated with the development of @DISEASE$ and adult antisocial behavior in males.	0
Our data suggest that the @GENE$-Y2R pathway may influence @DISEASE$ through a sex-specific mechanism, but this finding requires confirmation in other populations.	0
The significance of the G(-930)A polymorphism of @GENE$ was confirmed in the present study with adequate statistical power, which strengthens the hypothesis that this polymorphism is important in the pathogenesis of @DISEASE$ and confers susceptibility.	1
Ala(-9)Val substitution in the Mn-@GENE$ gene was associated with DN in Egyptian diabetic children but not a significant factor in diabetic patients with @DISEASE$.	0
these results may provide further support for an association between the dysbindin gene (DTNBP1) and @DISEASE$, but not between the disease and DAO, DAOA, NRG1 and @GENE$ or with the interaction of these genes.	1
Mutations in the IGF-@GENE$ gene that lead to @DISEASE$ in the function or number of IGF-I receptors may also retard intrauterine and subsequent growth in humans.	0
Our results suggest lack of association between Gly460Trp polymorphism of @GENE$ gene and salt sensitivity of @DISEASE$ pressure in Polish hypertensives.	0
This @GENE$ gene polymorphism is not linked with the pathophysiological changes of @DISEASE$.	0
the mutations within the @GENE$ domain of EGFR were found to specifically occur in @DISEASE$ patients with a low exposure of tobacco smoking.	0
These results consistently suggest that @GENE$ may play an important role in prostate @DISEASE$.	0
Our results indicate that genetic polymorphisms affecting knee @DISEASE$ vary between populations (Japanese versus Caucasian) and sexes and indicate a role for ASPN, @GENE$, FRZB, and COL2A1 in Caucasians.	1
@GENE$ mutations were associated with idiopathic and familial @DISEASE$, whereas the contribution was less evident in alcoholic CP.	0
The rs4578621 and rs894160 polymorphisms of the @GENE$ gene are not major genetic determinants of @DISEASE$ and type 2 diabetes-related phenotypes in a random sample of French men and women.	0
Our novel observation of a differential effect of OC use on @DISEASE$ risk by PTCH1 1315Leu-carrier status suggests the interesting possibility of the Sonic hedgehog/Patched (SHH/@GENE$) signaling pathway being involved in hormone-induced development of breast carcinoma.	1
Our data show that the exon 1 (+49) polymorphism of the @GENE$ gene is associated with @DISEASE$ in African Americans.	1
These findings indicated that the polymorphism of @GENE$ but not TLR4 Asp299Gly mutation was associated with Chinese patients with colorectal cancer, and the CD14 gene may contribute to the predisposition to @DISEASE$.	1
Our results suggest that the G908R @DISEASE$ of the @GENE$/NOD2 gene, as well as the T allele and TT genotype of the CD14 promoter are associated with increased susceptibility for developing sarcoidosis.	0
We concluded that @GENE$ gene variants are significant risk factors for late onset @DISEASE$.	1
The allele encoding for low activity @GENE$, but not CYP17, may be a genetic risk factor for @DISEASE$ among Chinese women.	1
Our findings support the notion that mutations in the @GENE$ gene cause @DISEASE$.	0
It was clarified that the @DISEASE$ in vivo nicotine metabolism was caused by @GENE$*7 and CYP2A6*10 alleles.	0
There was no evidence in this study for the association of @GENE$ M235T and ACE I/D polymorphism with @DISEASE$ in Chinese population in Chengdu area.	1
These results show that association of the LMP 2 locus with @DISEASE$ is due to linkage disequilibrium with the associated HLA haplotype @GENE$*0304-DQB1*02-DQA1*0501.	0
The reproducible, dose-dependent association of @GENE$ D302H with @DISEASE$ indicates the potential importance of inherited variation in the apoptosis pathway in breast cancer susceptibility.	1
These data suggest that this IL-1beta promoter polymorphism does not act as a strong susceptibility factor for @DISEASE$+@GENE$ in a population of individuals of European ancestry.	0
ccordingly, the Val(16)Ala polymorphism of Mn-@GENE$ may be unrelated to the etiology of @DISEASE$, but it seems to be associated with diabetic nephropathy in Japanese type 2 diabetic patients.	0
Our data indicate polymorphism in intron 4 of the PDCD1 gene affects the occurrence of @GENE$ and may slightly modify the risk of sporadic @DISEASE$.	0
Mutations within @GENE$ are a rare cause of SOD and @DISEASE$.	0
These findings suggested that @GENE$ and its receptor, KDR, genes contributed to the development of CAL in @DISEASE$ patients.	1
Together these findings indicate that the polymorphisms in the promoter region of @GENE$ are a genetic risk factor for @DISEASE$ by affecting promoter activity.	1
The -344C/T variant, but not the A6547G variant, of the @GENE$ gene may be a determinant of the @DISEASE$ pressure response to angiotensin-converting enzyme inhibitors in hypertensive patients.	0
Thus, together with @DISEASE$ and @GENE$ sleep behavior disorder, these findings suggest that specific DQB1 genes are implicated in disorders of motor control during sleep.	0
These results do not suggest that @GENE$ or PsPRODH contribute to the aetiology of schizophrenia, and that the putative @DISEASE$ susceptibility gene in 22q11 remains unknown.	1
Our data suggest that the @GENE$ genetic polymorphism analysed do not play a major role in the @DISEASE$ of T. cruzi infection in this Peruvian sample.	0
This study presents genetic evidence suggesting a potential role of @GENE$, but not @DISEASE$, in the inherited AA excess of PCOS.	0
Tunisian persons carrying the @GENE$/P2 genotype of the hsp70-2 gene may have an increased risk of @DISEASE$.	0
Polymorphisms of @GENE$ are associated with a higher risk of developing @DISEASE$, in particular early onset cervical carcinogenesis.	1
These results suggest that @GENE$ is a BMD determinant and also contributes to a risk of @DISEASE$.	0
Genetic variation in the @GENE$ promoter is likely to be highly involved in the production of @DISEASE$ in type 2 diabetic subjects.	0
The findings of this large study strongly support the notion that @GENE$ mutations characterize a subgroup of @DISEASE$ with good prognosis; patients with mutant TaG1 tumors have a higher risk of recurrence; and the F386L variant is selectively associated with low-grade tumors.	1
Results from the 89 @GENE$ families showed no deviation from the expected @DISEASE$ frequency of 0.5, from parents heterozygous for the A253 allele to either Graves' or unaffected offspring (Fisher's exact test p = 0.22) and, therefore, confirmed a lack of evidence of linkage disequilibrium between the A253 allele and GD.	0
No association was found between uterine @DISEASE$ and any polymorphisms in the AHRR, AHR, @GENE$, or CYP1A1 genes analyzed in the present study.	1
In conclusion, our data suggest that @GENE$ polymorphism is a genetic modifier of the @DISEASE$ of MS, possibly through inducing a partial defect in PD-1-mediated inhibition of T-cell activation.	0
Individuals homozygous for the @GENE$ @DISEASE$ had significantly lower grip strength but did not exhibit overt frailty.	0
Previously identified associations between smoking and @DISEASE$, whether microsatellite unstable or stable, appear to be explained by the association of smoking with CIMP and @GENE$ mutations.	0
These preliminary findings are suggestive of an association between @GENE$ and @DISEASE$.	1
SNP rs3744700 of @GENE$ gene is independently associated with the development of CAD in Chinese Han population, and GG homozygote which is associated with increased expression of CXCL16 may have a promoting effect on @DISEASE$.	1
This study shows that patients with @DISEASE$ have a higher frequency of @GENE$ T4065C TC genotype and T allele that supports a role of the PLAU T4065C polymorphism in determining the risk of MVP among the Chinese population in Taiwan.	1
The presence of the M280 polymorphism of the @GENE$ is associated with a decreased common carotid artery IMT, whereas the presence of the I249 polymorphism does not play a major role on the @DISEASE$ of carotid atherosclerosis.	0
In our study, genetic polymorphisms at the @GENE$ gene are associated with susceptibility for @DISEASE$, suggesting possible links between the serotonergic system and development of the disease.	0
Our data support a possible role of the @GENE$ gene in the vulnerability to @DISEASE$ in patients with auditory hallucinations, and suggest remarkable allele heterogeneity.	0
@GENE$ gene SNPs in the promoter and exon regions are not associated with susceptibility to @DISEASE$, but two of them in the promoter region are associated with phenotype of AD.	0
Mutations in exon 1 and the promoter of @GENE$ are not a common cause of @DISEASE$.	1
The consistent association between rs7903146 in @GENE$ and type 2 diabetes in different ethnic groups, including the Japanese population, suggests that TCF7L2 is a common susceptibility gene for @DISEASE$.	1
Our data suggested that these polymorphisms of the @GENE$ gene are unlikely to be major factors in the susceptibility to @DISEASE$ in the Japanese population studied.	1
These data do not support the notion that the @GENE$ gene plays a major role in risk for @DISEASE$ among Japanese individuals.	1
Due to skewed X-chromosome @DISEASE$, elderly women in populations with prevalent @GENE$ mutations are at risk of G6PD deficiency.	0
Even in these healthy young men, @GENE$-60 C > G allele was associated with effects on fasting insulin measures, and differences in @DISEASE$ and beta-cells function.	0
The lack of association between CD14 genotypes and IgE as well as @DISEASE$ outcomes in this large German study population seems to indicate that @GENE$ genotypes may not directly be involved in the development of allergies during childhood.	1
The presence of the @GENE$ Met66 allele does not contribute to the decreased level of GAD(67) mRNA expression in the prefrontal cortex of subjects with @DISEASE$.	1
The @GENE$ -174 G/C polymorphism modulates postoperative interleukin 6 levels and is associated with the degree of postoperative renal and pulmonary @DISEASE$ and in-hospital stay after coronary surgery.	0
The @GENE$ gene 572C/T polymorphism has no significant effect on the development and progression of @DISEASE$.	1
Our results indicate that common variants in the ATM, @GENE$ or ERBB2 genes are not involved in modifying @DISEASE$ survival or the risk of tumour-characteristic-defined breast cancer.	1
These data suggest that a G(-75)-->A @DISEASE$ of the @GENE$-I gene promoter, in addition to the common mutation of CETP gene, contributes to high HDL-C levels among hyperlipidemic patients in Japan.	0
the CX3CR1 1249 allele is associated with an increased risk of @DISEASE$ while the @GENE$ M280 allele might counteract the harmful influence of 1249.	1
Our results suggest that polymorphisms of the @GENE$ gene may play a role in the @DISEASE$ of KD.	0
The present prospective investigation provides further evidence for a protective role of @GENE$ gene variation in the risk of @DISEASE$ that was independent of the presence of diabetes.	0
Thus, in the present study on a small group with carefully characterised diabetic retinopathy phenotypes, there was no indication that @GENE$, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms were associated with severe @DISEASE$ in younger Type 1 diabetic patients.	0
@GENE$ polymorphisms may play an important role in the pathogenesis of @DISEASE$ in elderly Korean men.	1
@GENE$ @DISEASE$ should be included as indicator of resistance in the panel of markers used to predict response to EGFR-TKIs in NSCLC.	0
These data suggest that the @GENE$ promoter STR is unlikely to have a major genetic effect on the development of @DISEASE$ in the Japanese population.	1
The association of variants in @GENE$ with type 2 diabetes and type 2 diabetes-related phenotypes and the differential expression of IRS1 in adipocytes and skeletal muscle suggest a role of this gene in the @DISEASE$ of type 2 diabetes in Pima Indians.	0
Our results indicate that NEUROD1 and @GENE$ are not a common cause of either @DISEASE$ or late-onset Type II diabetes in the French Caucasian population.	1
These findings suggest that @GENE$ may play a role in the @DISEASE$ of type 2 diabetes and insulin resistance-related hypertension.	0
These results suggest that the IL-18 gene polymorphism is associated with a @DISEASE$ susceptibility, and there might be a gene-gene interaction between IL-18 gene with susceptible @GENE$ gene.	1
our results show that common variants in @GENE$ do not substantially influence risk of these two common @DISEASE$.	0
In conclusion, a significant association between @DISEASE$ and @GENE$ T51C polymorphism localized on chromosome 3p21 was found.	1
These results indicate that the T allele and TT genotype at CD14/-159 are risk factors for CAL in KD, and that the development of CAL in @DISEASE$ may be related to the magnitude of @GENE$ toll-like receptor response.	1
The results suggest that variation in @GENE$ affects risk of @DISEASE$ in the mestizo population of central Mexico (Mexico City and Orizaba) and in Mexican Americans (Starr County, Texas).	1
These findings suggest allelic variation in this region of @GENE$ is not a major independent risk factor for @DISEASE$, but may contribute to risk of disease in younger African-Americans or in the presence of certain immunogenetic markers.	0
The present study does not support that the investigated @GENE$ variants have a major influence on susceptibility to @DISEASE$ or related neurobiological traits.	1
The @GENE$ Y402H polymorphism may account for a substantial proportion of @DISEASE$ in individuals similar to those in the Rotterdam Study and may confer particular risk in the presence of environmental and genetic stimulators of the complement cascade.	1
We obtained evidence from two Caucasian study populations that the His298-allele of @GENE$ Arg298His confers to reduced risk of @DISEASE$.	1
These results suggest that the GG @GENE$ of the UCP-1 gene has a strong association with increased LDL cholesterol level and might be a significant risk factor for hyper-LDL cholesterolemia among Korean @DISEASE$ subjects.	0
Our data shows no association between @DISEASE$ and the Leu432Val polymorphism of the CYP1B1 gene or the tetranucleotide repeats of the @GENE$ gene.	1
Overall, our findings do not support a role for the T-->C 267 polymorphism of the @GENE$ receptor gene in response to clozapine, although replication is required to confirm this @DISEASE$.	0
The @GENE$ polymorphism and @DISEASE$ would not appear to be associated with risk of CAA in the elderly, although further study with larger samples is necessary for confirmation.	0
Deteriorating gallbladder contractions, possibly induced by alterations in the @GENE$ gene, as well as CCK-AR gene polymorphism, promoted @DISEASE$ formation.	1
Our results do not indicate an effect of @GENE$-64I on perinatal @DISEASE$ transmission and survival in Kenyan children.	0
It is unlikely that the promoter polymorphisms -359T/C and -303A/G of the catalytic subunit @GENE$ gene of human PI 3-kinase have a major impact on insulin secretion, insulin sensitivity, or the risk of @DISEASE$ in Finnish subjects.	1
Our data suggested that these polymorphisms of the @GENE$ gene are unlikely to be major factors in the susceptibility to @DISEASE$ in the Japanese population studied.	1
Although the effects of the A(-173) allele were recessive and although the @GENE$ genotype was found in just 0.7% of our study population, we observed that this variation of human SCNN1G had significant effects on @DISEASE$ pressure.	0
Variation in the preproghrelin gene is not associated with juvenile-onset @DISEASE$, @GENE$ 2 diabetes or related phenotypes among the examined Danish Caucasian subjects.	0
In conclusion, our findings support the hypothesis that @DISEASE$ and intron 11 C/A @GENE$ polymorphisms are linked in the Spanish population and may contribute to the risk of developing lung cancer probably due to a higher frequency of deletion of exon 12 and reduced DNA repair capacity of the XPC protein.	0
The results of this study link @GENE$ (@DISEASE$ Type 2 gene) to the formation of the clinically sporadic variants of vascular malformations of the CNS most commonly seen in patients with HHT, that is, AVMs and DAVFs.	0
These findings suggest that the presence of the variant allele in the promoter of @GENE$ or TIMP2 may be a protective factor for the development of @DISEASE$.	1
The deletion mutation in exon 11 in @GENE$ gene may be related to @DISEASE$ susceptibility in the Chinese population.	1
These data suggest that @GENE$ variation contributes to airway responsiveness in @DISEASE$.	1
The results indicate that @GENE$(V617F) @DISEASE$ is associated with clinical and morphological features of the myeloproliferative type of CMML.	0
The @GENE$ gene is less likely to play a substantial role in the development of atopy and @DISEASE$ in the Japanese population.	1
